Imaging of programmed cell death in arrhythmogenic right ventricle cardiomyopathy/dysplasia

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 8, 2011, Pages 1500-1506

  Campian, Maria E ^a   Tan, Hanno L ^a   Moerkerken, Astrid F Van ^a   Tukkie, Raymond ^b   Van Eck Smit, Berthe L F ^a   Verberne, Hein J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Kennemer Gasthuis ^*  (Netherlands)

Author keywords

99mTc annexin V scintigraphy; Apoptosis; Arrhythmogenic right ventricle cardiomyopathy dysplasia; Scintigraphy

Indexed keywords

LIPOCORTIN 5; TECHNETIUM 99M;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DRUG UPTAKE; FEMALE; HEART LEFT VENTRICLE WALL; HEART RIGHT VENTRICLE DYSPLASIA; HEART SCINTISCANNING; HEART VENTRICLE SEPTUM; HUMAN; IN VIVO STUDY; MALE;

ADULT; ANNEXIN A5; APOPTOSIS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BIOLOGICAL TRANSPORT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; YOUNG ADULT;

EID: 80052573910     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1817-x     Document Type: Article

References (25)

1. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360:1075-84.
2. Marcus FI, ZarebaW, Calkins H, Towbin JA, Basso C, BluemkeDA, et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results fromthe North American Multidisciplinary Study. Heart Rhythm. 2009;6:984-92.
3. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983-91. (Pubitemid 26292851)
4. van Heerde WL, Robert-Offerman S, Dumont E, Hofstra L, Doevendans PA, Smits JF, et al. Markers of apoptosis in cardiovascular tissues: Focus on Annexin V. Cardiovasc Res. 2000;45:549-59. (Pubitemid 30047121)
5. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349-54. (Pubitemid 28249015)
6. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet. 2000;356:209-12. (Pubitemid 30446976)
7. Hofstra L, Dumont EA, Thimister PW, Heidendal GA, DeBruine AP, Elenbaas TW, et al. In vivo detection of apoptosis in an intracardiac tumor. JAMA. 2001;285:1841-2. (Pubitemid 32289150)
8. Kietselaer BL, Reutelingsperger CP, Boersma HH, Heidendal GA, Liem IH, Crijns HJ, et al. Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med. 2007;48:562-7. (Pubitemid 47571410)
9. Narula J, Strauss HW. Invited commentary: P.S.* I love you: Implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. J Nucl Med. 2003;44:397-9. (Pubitemid 39586016)
10. Tokita N, Hasegawa S, Maruyama K, Izumi T, Blankenberg FG, Tait JF, et al. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging. 2003;30:232-8. (Pubitemid 36686842)
11. Campian ME, Verberne HJ, Hardziyenka M, de Bruin K, Selwaness M, van den Hoff MJ, et al. Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats. J Nucl Med. 2009;50:1371-7.
12. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom- Lundqvist C, Fontaine G, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994;71:215-8.
13. Awad MM, Calkins H, Judge DP. Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008;5:258-67. (Pubitemid 351593909)
14. Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 2008;82:809-21.
15. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-6. (Pubitemid 26339773)
16. James TN. Normal and abnormal consequences of apoptosis in the human heart. Annu Rev Physiol. 1998;60:309-25. (Pubitemid 28157876)
17. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, et al. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol. 1998;152:479-84. (Pubitemid 28106394)
18. Laufer EM, Reutelingsperger CP, Narula J, Hofstra L. Annexin A5: An imaging biomarker of cardiovascular risk. Basic Res Cardiol. 2008;103:95-104. (Pubitemid 351356752)
19. Hirt UA, Leist M. Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ. 2003;10:1156-64. (Pubitemid 37258581)
20. Brouckaert G, Kalai M, Krysko DV, Saelens X, Vercammen D, Ndlovu M, et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell. 2004;15:1089-100. (Pubitemid 38316218)
21. Campian ME, Verberne HJ, Hardziyenka M, de Groot EA, van Moerkerken AF, van Eck-Smit BL, et al. Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Nucl Med Mol Imaging. 2010;37:2079-85.
22. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation. 2003;108:3000-5. (Pubitemid 37553569)
23. Basso C, Ronco F, Marcus F, Abudureheman A, Rizzo S, Frigo AC, et al. Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: An in vitro validation of diagnostic criteria. Eur Heart J. 2008;29:2760-71.
24. Calabrese F, Basso C, Carturan E, Valente M, Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Is there a role for viruses? Cardiovasc Pathol. 2006;15:11-7. (Pubitemid 43088765)
25. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: Proposed modification of the task force criteria. Circulation. 2010;121:1533-41.